▶ 調査レポート

ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬のグローバル市場インサイト・予測（～2028年）
• 英文タイトル：Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Insights, Forecast to 2028

Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Insights, Forecast to 2028「ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬のグローバル市場インサイト・予測（～2028年）」（市場規模、市場予測）調査レポートです。• レポートコード：QY2203B06795
• 出版社/出版日：QYResearch / 2022年3月25日
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療
• 販売価格（消費税別）
  Single User￥725,200 (USD4,900)▷ お問い合わせ
  Multi User￥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License￥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の世界市場のxxx％を占める「酵素補充療法」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「ウォルマン病」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬のグローバル主要メーカーには、AstraZeneca plc、Merck & Co., Inc、Pfizer, Inc.、Alexion Pharmaceutical Inc、Lonza Group Ltd.、hermo Fisher Scientific、Teva Pharmaceutical Industries Ltd.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場は、種類と用途によって区分されます。世界のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
酵素補充療法、腎臓移植、幹細胞移植

【用途別セグメント】
ウォルマン病、コレステロールエステル蓄積症(CESD)

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬製品概要
- 種類別市場（酵素補充療法、腎臓移植、幹細胞移植）
- 用途別市場（ウォルマン病、コレステロールエステル蓄積症(CESD)）
- 調査の目的
・エグゼクティブサマリー
- 世界のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬販売量予測2017-2028
- 世界のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬売上予測2017-2028
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の地域別販売量
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬販売量
- 主要メーカー別ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬売上
- 主要メーカー別ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（酵素補充療法、腎臓移植、幹細胞移植）
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の種類別販売量
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の種類別売上
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の種類別価格
・用途別市場規模（ウォルマン病、コレステロールエステル蓄積症(CESD)）
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の用途別販売量
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の用途別売上
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の用途別価格
・北米市場
- 北米のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（種類別、用途別）
- 主要国別のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（種類別、用途別）
- 主要国別のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（種類別、用途別）
- 主要国別のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（種類別、用途別）
- 主要国別のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（種類別、用途別）
- 主要国別のライソゾーム酸性リパーゼ欠乏症（LALD）治療薬市場規模（トルコ、サウジアラビア）
・企業情報
AstraZeneca plc、Merck & Co., Inc、Pfizer, Inc.、Alexion Pharmaceutical Inc、Lonza Group Ltd.、hermo Fisher Scientific、Teva Pharmaceutical Industries Ltd.
・産業チェーン及び販売チャネル分析
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の産業チェーン分析
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の原材料
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の生産プロセス
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の販売及びマーケティング
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の産業動向
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬のマーケットドライバー
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の課題
- ライソゾーム酸性リパーゼ欠乏症（LALD）治療薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market
The global Lysosomal Acid Lipase Deficiency (LALD) Treatment market size is projected to reach US$ 860.9 million by 2028, from US$ 476.5 million in 2021, at a CAGR of 8.7% during 2022-2028.
Fully considering the economic change by this health crisis, Enzyme Replacement Therapy accounting for % of the Lysosomal Acid Lipase Deficiency (LALD) Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Wolman Disease segment is altered to an % CAGR throughout this forecast period.
China Lysosomal Acid Lipase Deficiency (LALD) Treatment market size is valued at US$ million in 2021, while the North America and Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lysosomal Acid Lipase Deficiency (LALD) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lysosomal Acid Lipase Deficiency (LALD) Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lysosomal Acid Lipase Deficiency (LALD) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lysosomal Acid Lipase Deficiency (LALD) Treatment market.
Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Scope and Market Size
Lysosomal Acid Lipase Deficiency (LALD) Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Lysosomal Acid Lipase Deficiency (LALD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Enzyme Replacement Therapy
Kidney Transplantation
Stem Cell Transplantation
Segment by Application
Wolman Disease
Cholesterol Ester Storage Disease (CESD)
By Company
AstraZeneca plc
Merck & Co., Inc
Pfizer, Inc.
Alexion Pharmaceutical Inc
Lonza Group Ltd.
hermo Fisher Scientific
Teva Pharmaceutical Industries Ltd.
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Enzyme Replacement Therapy
1.2.3 Kidney Transplantation
1.2.4 Stem Cell Transplantation
1.3 Market by Application
1.3.1 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Wolman Disease
1.3.3 Cholesterol Ester Storage Disease (CESD)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Perspective (2017-2028)
2.2 Lysosomal Acid Lipase Deficiency (LALD) Treatment Growth Trends by Region
2.2.1 Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Lysosomal Acid Lipase Deficiency (LALD) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Lysosomal Acid Lipase Deficiency (LALD) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Dynamics
2.3.1 Lysosomal Acid Lipase Deficiency (LALD) Treatment Industry Trends
2.3.2 Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Drivers
2.3.3 Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Challenges
2.3.4 Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lysosomal Acid Lipase Deficiency (LALD) Treatment Players by Revenue
3.1.1 Global Top Lysosomal Acid Lipase Deficiency (LALD) Treatment Players by Revenue (2017-2022)
3.1.2 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue
3.4 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Concentration Ratio
3.4.1 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue in 2021
3.5 Lysosomal Acid Lipase Deficiency (LALD) Treatment Key Players Head office and Area Served
3.6 Key Players Lysosomal Acid Lipase Deficiency (LALD) Treatment Product Solution and Service
3.7 Date of Enter into Lysosomal Acid Lipase Deficiency (LALD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lysosomal Acid Lipase Deficiency (LALD) Treatment Breakdown Data by Type
4.1 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Forecasted Market Size by Type (2023-2028)
5 Lysosomal Acid Lipase Deficiency (LALD) Treatment Breakdown Data by Application
5.1 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size (2017-2028)
6.2 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type
6.2.1 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022)
6.2.2 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028)
6.2.3 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Type (2017-2028)
6.3 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application
6.3.1 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022)
6.3.2 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028)
6.3.3 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Application (2017-2028)
6.4 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country
6.4.1 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2017-2022)
6.4.2 North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size (2017-2028)
7.2 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type
7.2.1 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022)
7.2.2 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028)
7.2.3 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Type (2017-2028)
7.3 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application
7.3.1 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022)
7.3.2 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028)
7.3.3 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Application (2017-2028)
7.4 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country
7.4.1 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2017-2022)
7.4.2 Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type
8.2.1 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application
8.3.1 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Region
8.4.1 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size (2017-2028)
9.2 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type
9.2.1 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Type (2017-2028)
9.3 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application
9.3.1 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Application (2017-2028)
9.4 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country
9.4.1 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type
10.2.1 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application
10.3.1 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country
10.4.1 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Details
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Lysosomal Acid Lipase Deficiency (LALD) Treatment Introduction
11.1.4 AstraZeneca plc Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
11.1.5 AstraZeneca plc Recent Developments
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Details
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc Lysosomal Acid Lipase Deficiency (LALD) Treatment Introduction
11.2.4 Merck & Co., Inc Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
11.2.5 Merck & Co., Inc Recent Developments
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Details
11.3.2 Pfizer, Inc. Business Overview
11.3.3 Pfizer, Inc. Lysosomal Acid Lipase Deficiency (LALD) Treatment Introduction
11.3.4 Pfizer, Inc. Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
11.3.5 Pfizer, Inc. Recent Developments
11.4 Alexion Pharmaceutical Inc
11.4.1 Alexion Pharmaceutical Inc Company Details
11.4.2 Alexion Pharmaceutical Inc Business Overview
11.4.3 Alexion Pharmaceutical Inc Lysosomal Acid Lipase Deficiency (LALD) Treatment Introduction
11.4.4 Alexion Pharmaceutical Inc Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
11.4.5 Alexion Pharmaceutical Inc Recent Developments
11.5 Lonza Group Ltd.
11.5.1 Lonza Group Ltd. Company Details
11.5.2 Lonza Group Ltd. Business Overview
11.5.3 Lonza Group Ltd. Lysosomal Acid Lipase Deficiency (LALD) Treatment Introduction
11.5.4 Lonza Group Ltd. Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
11.5.5 Lonza Group Ltd. Recent Developments
11.6 hermo Fisher Scientific
11.6.1 hermo Fisher Scientific Company Details
11.6.2 hermo Fisher Scientific Business Overview
11.6.3 hermo Fisher Scientific Lysosomal Acid Lipase Deficiency (LALD) Treatment Introduction
11.6.4 hermo Fisher Scientific Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
11.6.5 hermo Fisher Scientific Recent Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Details
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Lysosomal Acid Lipase Deficiency (LALD) Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Kidney Transplantation
Table 4. Key Players of Stem Cell Transplantation
Table 5. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Region (2017-2022)
Table 9. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Region (2023-2028)
Table 11. Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Trends
Table 12. Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Drivers
Table 13. Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Challenges
Table 14. Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Restraints
Table 15. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Lysosomal Acid Lipase Deficiency (LALD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment as of 2021)
Table 18. Ranking of Global Top Lysosomal Acid Lipase Deficiency (LALD) Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Lysosomal Acid Lipase Deficiency (LALD) Treatment Product Solution and Service
Table 22. Date of Enter into Lysosomal Acid Lipase Deficiency (LALD) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue Share by Application (2017-2022)
Table 30. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue Share by Application (2023-2028)
Table 32. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. AstraZeneca plc Company Details
Table 63. AstraZeneca plc Business Overview
Table 64. AstraZeneca plc Lysosomal Acid Lipase Deficiency (LALD) Treatment Product
Table 65. AstraZeneca plc Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022) & (US$ Million)
Table 66. AstraZeneca plc Recent Developments
Table 67. Merck & Co., Inc Company Details
Table 68. Merck & Co., Inc Business Overview
Table 69. Merck & Co., Inc Lysosomal Acid Lipase Deficiency (LALD) Treatment Product
Table 70. Merck & Co., Inc Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022) & (US$ Million)
Table 71. Merck & Co., Inc Recent Developments
Table 72. Pfizer, Inc. Company Details
Table 73. Pfizer, Inc. Business Overview
Table 74. Pfizer, Inc. Lysosomal Acid Lipase Deficiency (LALD) Treatment Product
Table 75. Pfizer, Inc. Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022) & (US$ Million)
Table 76. Pfizer, Inc. Recent Developments
Table 77. Alexion Pharmaceutical Inc Company Details
Table 78. Alexion Pharmaceutical Inc Business Overview
Table 79. Alexion Pharmaceutical Inc Lysosomal Acid Lipase Deficiency (LALD) Treatment Product
Table 80. Alexion Pharmaceutical Inc Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022) & (US$ Million)
Table 81. Alexion Pharmaceutical Inc Recent Developments
Table 82. Lonza Group Ltd. Company Details
Table 83. Lonza Group Ltd. Business Overview
Table 84. Lonza Group Ltd. Lysosomal Acid Lipase Deficiency (LALD) Treatment Product
Table 85. Lonza Group Ltd. Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022) & (US$ Million)
Table 86. Lonza Group Ltd. Recent Developments
Table 87. hermo Fisher Scientific Company Details
Table 88. hermo Fisher Scientific Business Overview
Table 89. hermo Fisher Scientific Lysosomal Acid Lipase Deficiency (LALD) Treatment Product
Table 90. hermo Fisher Scientific Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022) & (US$ Million)
Table 91. hermo Fisher Scientific Recent Developments
Table 92. Teva Pharmaceutical Industries Ltd. Company Details
Table 93. Teva Pharmaceutical Industries Ltd. Business Overview
Table 94. Teva Pharmaceutical Industries Ltd. Lysosomal Acid Lipase Deficiency (LALD) Treatment Product
Table 95. Teva Pharmaceutical Industries Ltd. Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Enzyme Replacement Therapy Features
Figure 3. Kidney Transplantation Features
Figure 4. Stem Cell Transplantation Features
Figure 5. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Application: 2021 VS 2028
Figure 6. Wolman Disease Case Studies
Figure 7. Cholesterol Ester Storage Disease (CESD) Case Studies
Figure 8. Lysosomal Acid Lipase Deficiency (LALD) Treatment Report Years Considered
Figure 9. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Share by Players in 2021
Figure 13. Global Top Lysosomal Acid Lipase Deficiency (LALD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Acid Lipase Deficiency (LALD) Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Lysosomal Acid Lipase Deficiency (LALD) Treatment Revenue in 2021
Figure 15. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Type (2017-2028)
Figure 17. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Application (2017-2028)
Figure 18. North America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Share by Country (2017-2028)
Figure 19. United States Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Type (2017-2028)
Figure 23. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Application (2017-2028)
Figure 24. Europe Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Share by Country (2017-2028)
Figure 25. Germany Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Share by Region (2017-2028)
Figure 35. China Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Share by Country (2017-2028)
Figure 45. Mexico Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size Share by Country (2017-2028)
Figure 51. Turkey Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Lysosomal Acid Lipase Deficiency (LALD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. AstraZeneca plc Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
Figure 55. Merck & Co., Inc Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
Figure 56. Pfizer, Inc. Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
Figure 57. Alexion Pharmaceutical Inc Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
Figure 58. Lonza Group Ltd. Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
Figure 59. hermo Fisher Scientific Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
Figure 60. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Lysosomal Acid Lipase Deficiency (LALD) Treatment Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

関連レポート
  • 温熱療法用装置のグローバル市場2021
    Global Hyperthermia Devices Sales Market Report 2021
    QAF27214 2021年5月25日 149Pages
    本市場調査資料では、世界の温熱療法用装置市場について種類別（マイクロ波温熱療法用装置、超音波温熱療法用装置）、用途別（病院、診療所、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、...
  • 世界の子宮内膜吸引キュレット市場 2028年：滅菌子宮内膜吸引キュレット、非滅菌子宮内膜吸引キュレット
    Global Endometrial Suction Curettes Market Insights, Forecast to 2028
    QY2207C3549 2022年7月11日 107Pages
    新型コロナウイルス感染症のパンデミックにより、世界の子宮内膜吸引キュレットの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に子宮内膜吸引キ...
  • 世界の胚移植＆IUIカテーテル市場 2028年：ストレートETカテーテル、プレカーブETカテーテル、子宮内授精カテーテル
    Global Embryo Transfer and IUI Catheters Market Insights, Forecast to 2028
    QY2207C3537 2022年7月11日 87Pages
    新型コロナウイルス感染症のパンデミックにより、世界の胚移植＆IUIカテーテルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に胚移植＆IU...
  • 世界のCD47（IAP）市場 2028年：CD47モノクローナル抗体、CD47ダブル抗体、CD47融合タンパク質
    Global CD47 (IAP) Market Insights, Forecast to 2028
    QY2207C3850 2022年7月11日 112Pages
    新型コロナウイルス感染症のパンデミックにより、世界のCD47（IAP）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にCD47（IAP）...
  • 世界の結膜炎治療市場 2028年：抗生物質、錠剤、軟膏
    Global Conjunctivitis Treatment Market Insights, Forecast to 2028
    QY2207C3480 2022年7月11日 78Pages
    新型コロナウイルス感染症のパンデミックにより、世界の結膜炎治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に結膜炎治療の世界市場のxx...
  • 世界のカテーテルシース市場 2028年：コモンシース、漏れ防止シース、ピーリングカテーテルシース
    Global Catheter Sheath Market Insights, Forecast to 2028
    QY2207C3663 2022年7月11日 114Pages
    新型コロナウイルス感染症のパンデミックにより、世界のカテーテルシースの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカテーテルシースの世...
  • 世界のFTIR分光消耗品市場 2028年：乾燥剤、反射付属品、ATR付属品、イメージング付属品、バッテリー、その他
    Global FTIR Spectroscopy Consumables Market Insights, Forecast to 2028
    QY2207C3605 2022年7月11日 107Pages
    新型コロナウイルス感染症のパンデミックにより、世界のFTIR分光消耗品の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にFTIR分光消耗品...
  • 超硬チップ付持針器のグローバル市場2021
    Global Carbide Tipped Needle Holders Sales Market Report 2021
    QAF27024 2021年5月25日 147Pages
    本市場調査資料では、世界の超硬チップ付持針器市場について種類別（ナローストレートジョー、ファインストレートジョー、ワイドストレートジョー、マイクロストレートジョー、スプリングハンドル付きスクリューロック、カーブジョー、鋸歯状ジョー）、用途別（外科手術、歯科手術、獣医外科、その他）、地域別（アメリカ、...
  • コンタクトレンズ溶液のグローバル市場2021
    Global Contact Lens Solution Sales Market Report 2021
    QAF27629 2021年5月25日 149Pages
    本市場調査資料では、世界のコンタクトレンズ溶液市場について種類別（120ml /ユニット、360ml /ユニット、500ml /ユニット、その他）、用途別（多機能、単機能）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規...
  • 世界のガンマアミノ酪酸（GABA）受容体アゴニスト市場 2028年：経口、非経口、髄腔内、その他
    Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Insights, Forecast to 2028
    QY2207C3462 2022年7月11日 110Pages
    新型コロナウイルス感染症のパンデミックにより、世界のガンマアミノ酪酸（GABA）受容体アゴニストの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、20...